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Sulforaphane Induces Antioxidative and Antiproliferative 
Responses by Generating Reactive Oxygen Species in Human 
Bronchial Epithelial BEAS-2B Cells 
Sulforaphane (SFN) is a naturally occurring compound which is known to induce the phase 
II antioxidant genes via Nrf2 activation, although the underlying mechanism has not been 
fully elucidated. In this study, we investigated Nrf2 induction in response to SFN in human 
bronchial epithelial BEAS-2B cells and determined the signaling pathways involved in this 
process. SFN treatment reduced cell viability. Prior to cell death, intracellular reactive 
oxygen species (ROS) were generated at a high rate within a minute of commencing SFN 
treatment. Pretreatment with antioxidant N-acetylcysteine (NAC) blocked SFN-induced 
decrease in cell growth. Erk1/2 was activated within 30 min of SFN addition, whereas Akt 
phosphorylation did not significantly change until the first 8 hr after SFN treatment but 
then became substantially low until 48 hr. Inhibition of Erk1/2 phosphorylation attenuated 
SFN-induced loss of cell viability. Nrf2 protein levels in both nuclear and whole cell lysates 
were increased by SFN treatment, which was dependent on ROS production. Knockdown 
of Nrf2 with siRNA attenuated SFN-induced heme oxygenase-1 (HO-1) up-regulation. 
Induction of the Nrf2/HO-1 after SFN treatment was potently suppressed by pretreatment 
with NAC. Overall, our results indicate that SFN mediates antioxidative and antiproliferative 
responses by generating ROS in BEAS-2B cells.
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ORIGINAL ARTICLE
Respiratory Diseases
INTRODUCTION
Molecular epidemiological studies have demonstrated a strong 
inverse relationship between the consumption of dietary iso-
thiocyanate (ITC) and the risk of various types of malignancies, 
particularly lung and the gastrointestinal tract (1). The ability of 
cruciferous vegetables to protect against neoplastic disease has 
been attributed to their high glucosinolates content. One of the 
most commonly studied glucosinolates is glucoraphanin, which 
contains 4-methylsulfinylbutyl group. Myrosinase-mediated 
hydrolysis of glucoraphanin results in generation of sulforaphane 
(SFN) responsible for antioxidant, antiproliferative and anticar-
cinogenic properties (2). 
  SFN (1-isothiocyanato-4-[methylsulfinyl]-butane) is a natu-
rally occurring ITC with promising chemopreventive activity. 
SFN induces cell cycle arrest and apoptosis in many types of can-
cer cells (3, 4) and inhibits the progression of benign tumors to 
malignant tumors, angiogenesis and endothelial cell functions, 
and the metastatic process (5). SFN also induces the phase II 
carcinogen detoxification enzymes such as glutathione trans-
ferases, UDP-glucuronyltransferase, NAD(P)H:quinone oxido-
reductase I and heme oxygenase-1 (HO-1), thereby allowing a 
diverse array of electrophilic and oxidative toxicants to be elim-
inated or inactivated before they cause damage to critical cellu-
lar macromolecules (6). The expression of the phase II enzymes 
is under the control of promoter sequence known as the antiox-
idant response element (ARE). The activity of ARE promoter is 
modulated by NF-E2-related factor 2 (Nrf2), which is seques-
trated by its cytoplasmic partner, Kelch-like ECH-associated pro-
tein 1 (Keap1), which promotes its ubiquitination and degrada-
tion by the proteasome (7). Modification of two crucial cysteine 
residues (C273 and C288) on the Keap1 by oxidation, alkylation, 
or arylation results in the dissociation of Keap1/Nrf2 complex 
and translocation of Nrf2 to the nucleus, where it binds to pro-
moters containing the ARE sequence and activates the transcrip-
tion of a series of detoxification enzymes (8). Therefore, activa-
tion of the Nrf2 pathway in cells plays a central role in enhanc-
ing the antioxidative capacity in the protection of cells and tis-
sues from oxidative damage. In this regard, enhancement of an-
tioxidant capacity by SFN might induce positive responses such 
as increases in cell survival by elevated expression of ROS-scav-
enging molecules. It may protect normal cells from chemother-
apy and radiotherapy that involve free radical mechanisms of 
cytotoxicity.Lee Y-J, et al.  •  Sulforaphane-induced Antioxidative Response
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  Like a multitude of synthetic substances, dietary phytochem-
icals selectively dysregulate cellular pathways and restore apop-
tosis in certain tumor cells while at the same time showing low 
toxicity in normal cells (9). Low doses of SFN exert antioxidant 
properties via Nrf2-mediated gene expression and higher doses 
result in pro-oxidant properties (10). At high concentrations, SFN 
is able to increase oxidative stress in tumor cells and continue 
to have beneficial anti-tumor effects by exerting cytotoxic effects. 
These benefits rely on ROS and SFN concentration to produce 
either antioxidant or pro-oxidant effects. The formation of ROS 
in cells does not only induce oxidative stress but also leads to 
the development of adaptive survival responses that result in 
enhanced tolerance to the subsequent cytotoxicity. A number 
of molecules likely contribute to this protection, including thiol-
rich metal-binding protein, metallothionein, γ-glutamylcysteine 
synthetase, glutathione S-transferase, and HO-1 (11). As previ-
ously reported, Nrf2/ARE activation is required for HO-1 induc-
tion in response to oxidative/electrophile stress (12). Several 
signaling pathways, including phosphatidylinositol 3-kinase 
(PI3K), protein kinase C (PKC), and mitogen-activated protein 
kinase (MAPK), are implicated in HO-1 induction (13). 
  SFN also induces Nrf2 activation through interactions with 
intracellular signaling networks, including PI3K/Akt, MAPK and 
PKC (14). Nrf2 phosphorylation by these kinases induces the 
release of Nrf2 from its repressor Keap1, thereby facilitating the 
translocation of Nrf2 to the nucleus (15). Indeed, overexpres-
sion or activation of MAPKs and PI3K/Akt is associated with the 
modulation of ARE-driven gene expression via Nrf2 activation 
(10). Nevertheless, the mechanisms by which these signaling 
pathways activate Nrf2 appear to be pleiotropic and cell type-
specific. Therefore, studies on the mutual interactions that oc-
cur between various protein kinases and Nrf2 in human bron-
chial epithelial cells may provide an efficient approach to under-
standing the intracellular antioxidant defense by SFN in pulmo-
nary diseases. To explore this we utilized a human bronchial ep-
ithelial cell line, BEAS-2B, as an in vitro model for Nrf2 activation 
by SFN. 
  Based on these findings, the present study was performed to 
investigate positive (Nrf2/HO-1 induction) or negative (antip-
roliferation) response by SFN and to evaluate upstream signal-
ing molecules involved in these processes with the aim of a bet-
ter understanding the regulatory mechanism of Nrf2/HO-1 in-
duction.
MATERIALS AND METHODS
Reagents and cell culture
Sulforaphane, N-acetylcysteine (NAC), 2´,7´-dichlorofluoresce-
in diacetate (DCF-DA), sodium dodecyl sulfate (SDS), dimeth-
ylsuldoxide (DMSO), cycloheximide (CHX), and antibody to 
β-actin were obtained from Sigma-Aldrich Co. (St. Louis, MO, 
USA). Ly294002 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopy-
ran-4-one], and PD98059 (2´-amino-3´-methoxyflavone) were 
purchased from Calbiochem (La Jolla, CA, USA). Anti-human 
Nrf2 antibody, HRP-tagged secondary antibodies, and enhanced 
chemiluminescence (ECL) kit were purchased from Santa Cruz 
Biotechnology (Santa Cruz, CA, USA). Rabbit anti-human Akt, 
phospho-Akt (p-Akt), Erk1/2, and phospho-Erk1/2 (p-Erk) an-
tibodies were from Cell Signaling Technologies (Beverly, MA, 
USA). Antibody against HO-1 was obtained from Stressgen Bio-
technologies (San Diego, CA, USA). Cell culture media and re-
agents were purchased from Invitrogen (Carlsbad, CA, USA). 
The human bronchial epithelial cell line, BEAS-2B, was obtained 
from the American Type Culture Collection (ATCC, Rockville, 
MD, USA) and maintained in BEBM basal medium supplement-
ed with 5% fetal bovine serum and BEGM SingleQuot kit (hy-
drocortisone, bovine pituitary extract, insulin, gentamycin sul-
fate, retinoic acid, transferrin, triiodothyronine, epinephrine, 
and human epidermal growth factor). Cells were grown to 70% 
confluence in a monolayer culture in this medium for 24 hr be-
fore treatment.
Cell viability assay
Cell viability was measured using the Cell Proliferation kit II 
(XTT) according to the manufacturer’s instruction (Roche Diag-
nostics, Indianapolis, IN, USA). Briefly, cells were seeded in 96-
well microtiter plates and then treated with SFN or other chem-
icals at various concentrations for the indicated times. After in-
cubation, 50 μL of XTT labeling mixture was added to each well 
and incubated for an additional 4 hr. The formazan dye formed 
was measured spectrophotometrically at 450 nm using a Glo-
max multi detection system (Promega, Madison, WI, USA). The 
results were expressed as an absorbance value or a percentage, 
based on the ratio of the absorbance of treated cells to that of 
controls (100%).
Determination of intracellular reactive oxygen species 
(ROS) levels
Intracellular ROS levels were measured using DCF-DA. Briefly, 
cells were treated with media or SFN at different concentrations 
for the indicated times, after which they were loaded with 10 μM 
of DCF-DA for 20 min. Next, the cells were harvested and washed 
twice with 1 × PBS to remove all excess DCF-DA that had not pen-
etrated into the cells. The relative fluorescence of 30,000 live cells 
per group was measured at excitation and emission wavelengths 
of 485 and 530 nm, respectively, using a multi-well fluorescence 
plate reader. Using untreated cells as a reference, the intracellu-
lar ROS levels were calculated by the average of three measure-
ments and expressed as a percentage of untreated controls.
Preparation of nuclear and cytosolic protein extracts 
Nuclear extracts were prepared according to the instructions of Lee Y-J, et al.  •  Sulforaphane-induced Antioxidative Response
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the NE-PER
® nuclear and cytoplasmic extraction kit (Pierce, 
Rockford, IL, USA). Briefly, cells were harvested at the indicated 
time, and were then re-suspended in 10 vol of CER I solution, 
after which they were incubated in CER II solution on ice for           
1 min and homogenized. Nuclei were recovered by centrifuga-
tion at 14,000 rpm for 5 min, and the supernatant was kept as 
the cytosolic protein extract. The nuclear fraction was extracted 
for 40 min on ice in NER solution. The insoluble pellet was re-
moved by centrifugation at 14,000 rpm for 10 min. The super-
natant was used as the nuclear protein extract. Nrf2 levels in nu-
clear and cytosolic extracts were determined by Western blot-
ting using anti-Nrf2 antibody.
RNA interference of Nrf2
RNA interference of Nrf2 was performed using an Nrf2-specific 
siRNA duplex from Invitrogen (Cat# 12990). Briefly, cells were 
seeded in 6-well and transfected at 50% confluency with siRNA 
duplex (20 nM) using lipofectamine RNAiMAX (Invitrogen) ac-
cording to the manufacturer’s recommendations. Cells trans-
fected with Stealth RNAi negative control duplex (Invitrogen) 
were used as controls for direct comparison. After transfection, 
cells were treated with DMSO or SFN (10 μM) for the indicated 
times, after which they were processed for Western blotting.
Western blot analysis
Whole cell lysates were prepared using RIPA buffer (1 × PBS, 1% 
NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 10 μg/mL phenyl-
methanesulfonylfluoride). Briefly, proteins (40 μg per lane) were 
separated on NuPAGE 4-12% bis-tris polyacrylamide gels (Invi-
trogen) and then electrophoretically transferred to Immuno-Blot 
PVDF membranes. The membranes were then incubated for 2 hr 
at room temperature with a 1:500 dilution of anti-Nrf2, anti-HO-1, 
anti-p-Akt, and anti-p-Erk antibodies. Next, HRP-conjugated 
secondary antibody was applied at a dilution of 1:5,000 and the 
signal was visualized using an ECL detection kit. The blots were 
then stripped using a stripping buffer (100 mM β-mercaptoetha-
nol, 2% SDS, 62.5 mM Tris-HCl, pH 6.7) and re-probed with anti-
Akt, anti-Erk, and anti-β-actin antibodies as loading controls.
Statistical analysis
Statistical comparisons were made using one-way analysis of 
variance (ANOVA) followed by a Tukey’s post hoc correction for 
multiple comparisons using SPSS version 17.0 (SPSS Inc., Chi-
cago, IL, USA). Data were expressed as the mean ± SEM. Signif-
icant differences were considered with values of P < 0.05.
RESULTS
SFN inhibits cell growth by inducing a rapid increase in 
intracellular ROS levels
The effect of SFN on cell proliferation was examined by XTT as-
say after treatment with different doses (0, 5, 10 or 20 μM) of SFN 
for 24, 48, and 72 hr. Exposure of cell cultures to increasing con-
centrations of SFN led to a decrease in cell proliferation. As shown 
in Fig. 1A, treatment with doses of 5, 10 and 20 μM SFN resulted 
in a decrease in cell viability to approximately 97.7, 84.5, and 
68.4% of that of control cells, respectively. A time-response ex-
periment showed that treatment with 10 μM SFN decreased the 
number of living cells from approximately 84.5% of that of con-
trol cells at 24 hr treatment to 78.3% at 72 hr. 
  In order to investigate whether ROS can be produced under 
our experimental conditions, we pre-loaded BEAS-2B cells with 
the ROS-sensitive fluorophore DCF-DA, prior to treatment with 
SFN, and then measured DCF-DA fluorescence. As shown in 
Fig. 1B, ROS production was rapidly initiated within 10 min after 
SFN addition, peaked at 8 hr, and then gradually declined until 
48 hr. To confirm that the SFN-induced decrease in cell viability 
is indeed due to its induction of ROS generation, cells were pre-
treated with NAC (5 mM) for 1 hr, and then exposed to SFN (0-
20 μM) for 72 hr. In samples co-treated with NAC and SFN, cell 
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Fig. 1. Effects of SFN on cell proliferation and intracellular ROS levels. (A) BEAS-2B cells were treated with various concentrations (0-20 µM) of SFN for 24, 48, and 72 hr. After 
XTT assay, absorbance values were measured spectrophotometrically at 450 nm. (B) Cells were treated with SFN (10 µM) for the indicated time. The level of ROS generated 
was then measured by using the redox-sensitive dye DCF-DA. (C) Cells were treated with NAC (5 mM) for 1 hr prior to incubation with various concentrations (0-20 µM) of SFN 
for 72 hr. The percentage of viable cells was then determined by XTT assay. Error bars represent the mean ± SEM for three independent experiments. In panel C, values with 
different letters were significantly different from each other (P < 0.05).*P < 0.05 compared to control.Lee Y-J, et al.  •  Sulforaphane-induced Antioxidative Response
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Fig. 2. SFN-induced phosphorylation of Akt and Erk1/2. (A) BEAS-2B cells were treated with SFN (10 µM) for the indicated time. (B) Cells were treated with various concentra-
tions (0-20 µM) of SFN for 2 hr or 24 hr. (C) Cells were treated with or without NAC (5 mM) for 1 hr prior to incubation with the indicated concentrations of SFN for 2 hr or 24 
hr. Cell lysates were analyzed by Western blot analysis with anti-p-Akt and anti-p-Erk antibodies. The blots were then stripped and re-probed with anti-Akt and anti-Erk antibod-
ies as loading controls. (D) Cells were treated with or without Ly294002 (20 µM) and PD98059 (50 µM) for 1 hr prior to incubation with the indicated concentrations of SFN for 
72 hr. The percentage of viable cells was then determined by XTT assay. In the box, values with different letters were significantly different from each other (P < 0.05). *P < 
0.05 compared to control.
  O  S
  0  5  10  20
  -  -  -  +  +  +
  -  5  10  -  5  10
  -  -  -  +  +  +
  -  5  10  -  5  10
NAC 
SFN
NAC 
SFN
  0  5  10  20
  O  S   O  S   O  S   O  S   O  S   O  S   O  S
10 min
2 hr
2 hr 24 hr
24 hr
30 min 2 hr 1 hr 4 hr 8 hr 24 hr
p-Erk
p-Erk
p-Erk p-Erk
(µM)
(µM) (µM)
Erk
Erk
Erk Erk
p-Akt
p-Akt
p-Akt p-Akt
Akt
Akt
Akt Akt
48 hr
B
C
R
e
l
a
t
i
v
e
 
d
e
n
s
i
t
y
 
 
(
%
 
c
o
n
t
r
o
l
)
R
e
l
a
t
i
v
e
 
d
e
n
s
i
t
y
 
 
(
%
 
c
o
n
t
r
o
l
)
300
200
100
0
600
400
200
0
p-Erk p-Erk p-Akt p-Akt
*
*
*
*
*
*
*
* *
* *
* *
* *
* *
D
C
e
l
l
 
v
i
a
b
i
l
i
t
y
 
(
%
 
c
o
n
t
r
o
l
)
140
120
100
80
60
40
20
0
SFN concentration (µM)
SFN conc. (µM)  0  5  10  20
SFN  100.0
a  83.0
a  68.1
a  52.4
a
SFN + Ly  100.0
a  88.9
a  71.5
a  59.2
a
SFN + PD  100.0
a  78.4
a  60.0
b  50.6
a
  5  10  15  20
SFN
SFN + Ly
SFN + PD
A
viability was maintained in almost the same range as untreated 
controls (Fig. 1C). These results suggest that ROS play a critical 
role in antiproliferative response by SFN.
Erk1/2 phosphorylation is involved in SFN-induced 
decrease in cell viability 
To determine if PI3K/Akt or MEK/Erk1/2 signaling relates to 
antiproliferative effect induced by SFN, we evaluated the phos-
phorylation of Erk1/2 and Akt by immunoblot analysis with whole 
cell lysates that were extracted from cells treated with SFN for the 
indicated time. Fig. 2A shows that SFN slightly induced Erk1/2 
phosphorylation within 30 min of treatment, and then consis-
tently increased it. However, Akt phosphorylation remained un-
changed until the first 8 hr of SFN treatment, and then suppressed 
slightly below control levels throughout 48 hr. Effects of SFN on 
the phosphorylation of Erk1/2 and Akt were also observed in 
dose-response study. Additionally, the potential role of ROS sig-
naling in SFN-mediated phosphorylation of AKT and Erk1/2 
was evaluated using the free radical scavenger NAC. Pretreat-
ment of cells with NAC blocked Akt phosphorylation at 2 hr or 
24 hr after SFN treatment and, to a much lesser extent, Erk1/2 
phosphorylation (Fig. 2B, C). We then examined cell viability 
during inhibition of MEK and PI3K activities using Ly294002 for 
PI3K and PD98059 for MEK. For this purpose, the cells were pre-
treated with or without inhibitors prior to treatment with differ-
ent doses of SFN for 72 hr. The results indicated that pretreatment 
of these cells with PD98059 significantly blocked cell growth 
only at 10 μM SFN treatment (P < 0.05), whereas Ly294002 did 
not significantly affect it (Fig. 2D).
SFN increases the nuclear translocation of Nrf2 via ROS-
dependent pathways
The nuclear accumulation of Nrf2 is usually considered a marker 
of Nrf2 activation in response to stressors. As shown in Fig. 3A, 
SFN treatment rapidly increased the level of Nrf2 in the nuclear 
fractions as expected, whereas only a weak signal of the cyto-
plasmic Nrf2 band was obtained. However, pretreatment of cells 
with NAC effectively inhibited the ability of SFN to increase Nrf2 
protein levels. Similar findings were also observed in experiments 
using whole cell lysates. Next, we determined whether MEK/
Erk1/2 and PI3K/Akt pathways were involved in SFN-induced 
increase in Nrf2 level at early time point (2 hr). Results showed 
that Nrf2 level was significantly suppressed in cells pretreated 
with Ly294002 and responded to some extent to PD98059 (Fig. Lee Y-J, et al.  •  Sulforaphane-induced Antioxidative Response
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Fig. 3. Effects of various chemical inhibitors on SFN-induced Nrf2 activation. (A) BEAS-2B cells were treated with NAC (5 mM) and cycloheximide (CHX, 200 nM) for 1 hr prior 
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the mean ± SEM for three independent experiments. *P < 0.05 compared to control.
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3B). These results imply that ROS and PI3K/Akt signalings play 
critical roles in induction of Nrf2 activation. 
Nrf2-mediated HO-1 induction by SFN is associated with 
ROS and PI3K signaling
Up-regulation of HO-1 has been found to be protective in lung 
against oxidative stress (16) and its expression is regulated by 
the transcription factor Nrf2 and multiple kinase signaling path-
ways. To confirm whether HO-1 expression is dependent on Nrf2 
activity, we employed a siRNA against Nrf2 mRNA. Cells were 
transfected with control siRNA or Nrf2-targeting siRNA for 48 hr. 
Suppression of Nrf2 expression by transfection with its siRNA 
completely abolished an increased in HO-1 protein induced by 
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Fig. 6. Comparison of the relative changes in intracellular levels of ROS, Nrf2, HO-1, 
p-Akt, and p-Erk1/2 after SFN (10 μM) treatment. For each sample, the expression of 
Nrf2, HO-1, p-Akt, and p-Erk1/2 were quantified by densitometry, and the ratios 
Nrf2:β-actin, HO-1:β-actin, p-Akt:Akt, and p-Erk1/2:Erk1/2 were calculated. Induc-
tion levels are depicted as absolute fold change compared to untreated controls (Y-
axis). *P < 0.05 compared to control.
SFN as well as constitutive level of HO-1 (Fig. 4A). In time-re-
sponse experiments, the induction of HO-1 by SFN was evident 
as early as 4 hr and augmentation lasted for at least 48 hr. Such 
effects were accompanied by an increase in Nrf2 levels (Fig. 4B).
  Regarding the signaling mechanisms of HO-1 induction, sev-
eral studies have suggested involvement of ROS (17). Therefore, 
we examined whether blockade of SFN-induced ROS genera-
tion could affect HO-1 expression at 24 hr after SFN treatment. 
Pretreatment with NAC inhibited an increase Nrf2 and HO-1 
protein levels induced by SFN, suggesting that the effects were 
mediated by ROS (Fig. 5A). Next, to investigate the role of Erk1/2 
and PI3K/Akt in SFN-induced HO-1 expression, we examined 
the effects of Ly294002 and PD98059 on SFN-induced HO-1 up-
regulation. As shown in Fig. 5B, pretreatment with Ly294002 or 
PD98059 inhibited SFN-induced increase in HO-1 level, where-
as no obvious changes were found on Nrf2 levels in cells pre-
treated with Ly294002. This finding suggests that PI3K/Akt sig-
naling may regulate HO-1 expression independently Nrf2 in re-
sponse to SFN. 
  Fig. 6 shows the time-course curves of the 5 parameters (ROS, 
Nrf2, HO-1, p-Akt, and p-Erk1/2) after SFN treatment. The in-
duction levels changed with several different kinetics patterns. 
The levels of ROS and Nrf2 increased abruptly at early time points. 
This increase in ROS levels was quite rapid, peaked at 8 hr after 
SFN treatment, and became substantially lower and remained 
below control levels at 24 hr. It may be due to an increase in an-
tioxidant capacity via Nrf2 activation. Meanwhile, Nrf2 levels in-
creased with similar rapidity and were maintained at high levels 
for 48 hr. Importantly, the rapid increase in HO-1 level contin-
ued only for the first 8 hr at best. It implies that up-regulation of 
HO-1 expression, at least at a later period, was not solely attrib-
utable to the levels of intracellular ROS and Nrf2. 
DISCUSSION
The antioxidant defense pathway is one mechanism by which 
the cells can respond to oxidative stress. It is also important to 
maintain cellular redox homeostasis and prevent the pathogen-
esis of many inflammatory and related diseases. A number of 
phytochemcals have been used to induce expression of antioxi-
dant proteins involved in scavenging ROS (11). Nrf2 is the key 
transcriptional factor that serves to transmit various signals to 
ARE, a cis-acting regulatory element, and that plays an impor-
tant role in a coordinated activation of genes encoding antioxi-
dant proteins. In this study, we have shown the antioxidative ef-
ficacy of SFN in human bronchial epithelial BEAS-2B cells, and 
that upstream signaling molecules involved in these processes 
could play a role in maintaining Nrf2 activity. In this study, the 
exposure of BEAS-2B cells to SFN elicited an increase in intracel-
lular oxidants, Erk1/2 phosphorylation, nuclear accumulation 
of Nrf2, up-regulation of HO-1 expression, and a decrease in cell Lee Y-J, et al.  •  Sulforaphane-induced Antioxidative Response
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growth. These events were effectively reversed by pretreatment 
with NAC, suggesting that antioxidative and antiproliferative 
effects induced by SFN in BEAS-2B cells are largely dependent 
on ROS. 
  Numerous studies on SFN toxicity have dealt with oxidative 
stress. It has been proposed that SFN-induced ROS generation is 
mediated indirectly by targeting the mitochondrial respiratory 
chain, in addition to a nonmitochondrial mechanism involving 
depletion in intracellular GSH concentration (18, 19). In this 
study, SFN treatment resulted in a significant decrease in cell 
viability as well as an early increase in ROS levels. Moreover, the 
effect of SFN on cell viability was abrogated in the presence of 
NAC. It provides strong evidence for the involvement of oxida-
tive stress in antiproliferative effect induced by SFN. Some re-
ports suggest that the activation of Erk1/2 signaling by SFN is 
involved in its antiproliferatve effects (20). Our study revealed 
that SFN strongly induce Erk1/2 phosphorylation, which is due 
to, at least in part, ROS generated by SFN. However, it is not clear 
that Erk1/2 is involved in SFN-induced antiproliferation, because 
it was significantly attenuated by PD98059 only at 10 μM SFN. 
Further studies are needed to examine the consequences of en-
forced activation of Erk1/2 on the effects of SFN. 
  The relationships between oxidative stress responses and cel-
lular consequences are complicated due to the compensatory 
mechanisms regulating cellular fitness. ROS generated from en-
dogenous and exogenous sources could influence multiple cel-
lular processes, including signaling, proliferation, and apoptosis 
(21). We have shown that treatment of BEAS-2B cells with 10 μM 
SFN rapidly increased intracellular ROS levels, which was linked 
to Nrf2 activation. In addition, SFN treatment led to an increased 
level of Nrf2 protein in cells and such an effect was abrogated in 
the presence of NAC. These findings are supported by earlier 
reports that SFN not only requires Nrf2 activation for the induc-
tion of Phase II enzymes, but also increase the Nrf2 protein lev-
els (22). It is possible that the activation of Nrf2 is mediated by 
mechanisms that lead to its stabilization as well as the regula-
tion via its synthesis, thus increasing levels of cellular Nrf2 and 
subsequent transcriptional activation. Therefore, it would be 
rational to assume that significant increase in intracellular ROS 
concentrations, subsequently leading to the strong induction of 
HO-1 via the Nrf2 signaling, is a part of the defense system of 
BEAS-2B cells under oxidative stress. 
  In this study, because elevated ROS levels were then gradual-
ly decreased, presumably due to induction of antioxidant pro-
teins through Nrf2/ARE activation, we originally speculated that 
Nrf2 activation through transient ROS generation is the part of 
the early response, and that other pathways including MAPKs 
and PI3K/Akt may be involved in its activation by SFN. Howev-
er, chemical blockage of either Erk1/2 or Akt suppressed to some 
extent the increase of intracellular Nrf2 levels at 2 hr after SFN 
treatment. These findings suggest that activation of Erk1/2 or 
Akt at the early phase, at least in part, contributes to an increase 
in Nrf2 level by SFN.
  Although oxidative stress can cause cell death, moderate 
amounts of ROS may mediate the intracellular signal transduc-
tion leading to transcriptional activation of the adaptive genes. 
In agreement with this notion, our present study demonstrates 
that alterations of the cellular redox status by SFN immediately 
turn on the cellular signaling cascades in such a way activating 
HO-1 to rescue the cells from subsequent oxidative stress. HO-1 
catalyzes the degradation of pro-oxidant heme to biliverdin, car-
bon monoxide and ferrous ion, and has putative cytoprotective, 
antioxidative, and anti-inflammatory properties (23). Bronchial 
inflammation is a key feature of many diseases of the respirato-
ry tract and occurs as a consequence of inhalation of allergens 
and environmental pollutants, microbial infection, and cigarette 
smoking. Oxidant injury mediates many of the toxic effects in-
duced by environmental stressors and plays a pivotal role in the 
pathogenesis of pulmonary diseases (24).Therefore, roles of an-
tioxidants and enzymes neutralizing these harmful oxidants are 
extremely important in determination of the intracellular anti-
oxidant defense. Several reports have indicated that SFN, alone 
or in combination with other phytochemicals, induces over-pro-
duction of HO-1 protein, thus exerting its anti-inflammatory 
activities (25, 26). In various model systems, the increase of HO-1 
induction conferred protection on cells from injury and cytotox-
icity induced by oxidative stress, while the abrogation of its in-
duction accelerates cellular injuries (27). In this study, we ob-
served that SFN is capable of strongly increasing Nrf2 and HO-1 
protein levels and that their inductions are inhibited by pretreat-
ment with NAC. Knockdown of Nrf2 by siRNA potently blocked 
up-regulation of HO-1 expression by SFN. Together, these find-
ings indicate that SFN-induced increase in HO-1 levels is largely 
dependent on ROS/Nrf2 signaling. However, though Nrf2 levels 
were still maintained at high levels for the first 48 hr after SFN 
treatment, HO-1 levels became substantially low after the first  
8 hr. This result implies that that SFN is likely to induce HO-1 ex-
pression utilizing both Nrf2-dependent and -independent path-
ways. In our study, inhibition of Akt phosphorylation, at least   
in the late time point (24 hr), partially blocked up-regulation of 
HO-1 expression, whereas no obvious effects were found on Nrf2 
levels. This finding suggests the role of the Nrf2-independent 
pathway in the up-regulation of HO-1 expression in response to 
SFN. Similarly, there is evidence for up-regulation of HO-1 ex-
pression independently of Nrf2 in response to oleanolic acid (28). 
It is also reported that nerve growth factor induces the expres-
sion of HO-1 by an unknown PI3K‐dependent mechanism (29). 
Taken together, SFN seems to regulate up-regulation of HO-1 
expression via Nrf2-dependent and -independent mechanisms. 
Much remains to be learned about how HO-1 is regulated at the 
molecular level, however, change in the intracellular redox state 
to a more oxidized environment seems to serve as a signal that Lee Y-J, et al.  •  Sulforaphane-induced Antioxidative Response
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warns cells of the oxidative status, thereby triggering Nrf2/HO-1 
induction as part of the defense mechanism. 
  In summary, we have demonstrated that exposure of the BEAS-
2B cells to SFN induces antioxidative and antiproliferative effects 
via a ROS-mediated mechanism and at least in part, by modu-
lation of signaling mediated by PI3K and/or MEK/Erk1/2, which 
result in a marked increase of Nrf2 and HO-1 protein levels.
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Sulforaphane Induces Antioxidative and Antiproliferative Responses by Generating 
Reactive Oxygen Species in Human Bronchial Epithelial BEAS-2B Cells 
Yoon-Jin Lee and Sang-Han Lee
This study evaluated the ability of SFN to induce antioxidative and antiproliferative responses in human bronchial epithelial BEAS-
2B cells. SFN treatment induced an increase in intracellular oxidants, Erk1/2 phosphorylation, nuclear accumulation of Nrf2, up-
regulation of HO-1 expression, and a decrease in cell growth. Antioxidative and antiproliferative effects induced by SFN in BEAS-
2B cells are largely dependent on ROS. 